Browsing 162 ePresentations
Interdisciplinary Network Relevance- MCS
Filtered By
- MCS
Sort By
7 - Five Years Experience of Peripheral Veno-Arterial ECMO as Method of Mechanical Circulatory Support in Heart Transplant Candidates
Presentation Number
7
Session Name
SESSION 03 - ORAL: Planning for Success: Heart Transplantation after MCS
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
35 - Survival and Predictors of Mortality in Patients Undergoing RVAD Explant in IMACS
Presentation Number
35
Session Name
SESSION 08 - ORAL: Biventricular Failure
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- A. Patel, Dearborn, MI, United States of America
- G. Grafton, Detroit, MI, United States of America
- C. Tita, Northville, MI, United States of America
- B. Hannawi, Houston, TX, United States of America
- Y. Selektor, Franklin, MI, United States of America
- T. Chamogeorgakis, Detroit, MI, United States of America
- D. Apostolou, Detroit, MI, United States of America
- D. Lanfear, Detroit, MI, United States of America
- C. Williams, West Bloomfield, MI, United States of America
- H. Nemeh, Detroit, MI, United States of America
- J. Cowger, Detroid, MI, United States of America
38 - The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems
Presentation Number
38
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- J. Vieira, Boston, MA, United States of America
- M. Pfeffer, Lebanon, NH, United States of America
- B. Claggett, Boston, MA, United States of America
- J. Connors, Boston, MA, United States of America
- G. Stewart, Boston, MA, United States of America
- M. Givertz, Boston, MA, United States of America
- L. Coakley, Boston, MA, United States of America
- H. Mallidi, Boston, MA, United States of America
- M. Mehra, Pittsburgh, PA, United States of America
39 - Dysregulation of the Angiopoietin-2/Tie-2 Axis is Associated with Reduced Pulsatility and Increased Arteriovenous Malformation Related Gastrointestinal Bleeding Following Left Ventricular Assist Device Implantation
Presentation Number
39
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- J. Newman, Maywood, IL, United States of America
- Z. Hussain, Maywood, IL, United States of America
- F. Hussain, Maywood, IL, United States of America
- M. Poonawalla, Maywood, IL, United States of America
- E. Bontekoe, Maywood, IL, United States of America
- H. Ilias Basha, Maywood, IL, United States of America
- J. Fareed, Maywood, IL, United States of America
- A. Heroux, Maywood, IL, United States of America
- M. Liebo, Maywood, IL, United States of America
- J. Walenga, Maywood, IL, United States of America
- E. Raichlin, Maywood, IL, United States of America
41 - Association of Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on LVAD Support and Risk of Gastrointestinal Bleeding: A Multi-Center Analysis
Presentation Number
41
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- J. Schultz, Minneapolis, MN, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- J. Estep, Cleveland, OH, United States of America
- K. Goodwin, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- A. El Rafei, Minneapolis, MN, United States of America
- M. Pritzker, Minneapolis, MN, United States of America
- F. Kamdar, Minneapolis, MN, United States of America
- R. John, Minneapolis, MN, United States of America
- R. Cogswell, Minneapolis, MN, United States of America
42 - Association between Digoxin Use and Gastrointestinal Bleeding in Contemporary Continuous Flow Left Ventricular Assist Device Support
Presentation Number
42
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- A. El Rafei, Minneapolis, MN, United States of America
- B. Trachetenberg, Houston, TX, United States of America
- R. John, Minneapolis, MN, United States of America
- J. Estep, Cleveland, OH, United States of America
- J. Schultz, Minneapolis, MN, United States of America
- K. Goodwin, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- T. Thenappan, Minneapolis, MN, United States of America
- R. Cogswell, Minneapolis, MN, United States of America
61 - MAGGIC-Predicted Mortality of >20% at One Year is Associated with Poor Prognosis in Ambulatory Patients with Advanced Heart Failure
Presentation Number
61
Session Name
SESSION 16 - ORAL: Outpatient Heart Failure Risk Stratification: A Measure of All Things
Date
Wed, Apr 22, 2020
Time
04:15 PM - 06:00 PM
66 - External Validation of the Minnesota Pectoralis Muscle Risk Score to Predict Mortality after Ventricular Assist Device Implantation
Presentation Number
66
Session Name
SESSION 17 - ORAL: Patient Selection for LVAD Implantation
Date
Wed, Apr 22, 2020
Time
04:15 PM - 06:00 PM
Authors
- R. Cogswell, Minneapolis, MN, United States of America
- T. Murray, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- L. Teigen, Minneapolis, MN, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- J. Schultz, Minneapolis, MN, United States of America
- R. John, Minneapolis, MN, United States of America
- C. Martin, Minneapolis, MN, United States of America
- J. Estep, Cleveland, OH, United States of America
68 - External Validation and Comparison of the EUROMACS and Right Ventricular Failure Risk Score for Right Ventricular Failure Prediction after Left Ventricular Assist Device
Presentation Number
68
Session Name
SESSION 17 - ORAL: Patient Selection for LVAD Implantation
Date
Wed, Apr 22, 2020
Time
04:15 PM - 06:00 PM
Authors
- S. Kumar, Houston, TX, United States of America
- M. Rivas-Lasarte, Bronx, NY, United States of America
- S. Rashid, Bronx, NY, United States of America
- A. Scatola, New York, NY, United States of America
- Y. Rochlani, Bronx, NY, United States of America
- S. Murthy, New York, NY, United States of America
- O. Saeed, Bronx, NY, United States of America
- P. Chavez, Bronx, NY, United States of America
- S. Forest, Bronx, NY, United States of America
- J. Shin, Bronx, NY, United States of America
- S. Patel, Bronx, NY, United States of America
- S. Vukelic, Bronx, NY, United States of America
- D. Goldstein, Bronx, NY, United States of America
- U. Jorde, Bronx, NY, United States of America
- D. Sims, Bronx, NY, United States of America
93 - The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial
Presentation Number
93
Session Name
SESSION 29 - ORAL: Anticoagulation and Bleeding Complications in MCS Patients
Date
Thu, Apr 23, 2020
Time
02:00 PM - 03:45 PM
Authors
- O. Saeed, Bronx, NY, United States of America
- P. Columbo, New York, NY, United States of America
- M. Mehra, Pittsburgh, PA, United States of America
- N. Uriel, Bronx, NY, United States of America
- D. Goldstein, Bronx, NY, United States of America
- J. Cleveland, Colorado Springs, CO, United States of America
- J. Conners, Boston, MA, United States of America
- S. Najjar, Washington, DC, United States of America
- N. Mokadam, Columbus, OH, United States of America
- A. Bansal, New Orleans, LA, United States of America
- D. Crandall, Burlington, MA, United States of America
- P. Sood, Abbott Park, IL, United States of America
- U. Jorde, Bronx, NY, United States of America
96 - Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy
Presentation Number
96
Session Name
SESSION 29 - ORAL: Anticoagulation and Bleeding Complications in MCS Patients
Date
Thu, Apr 23, 2020
Time
02:00 PM - 03:45 PM
Authors
- U. Jorde, Bronx, NY, United States of America
- J. Katz, Chapel Hill, NC, United States of America
- P. Colombo, New York, NY, United States of America
- J. Stulak, Rochester, MN, United States of America
- D. Crandall, Burlington, MA, United States of America
- A. Franke, Sylmar, CA, United States of America
- R. Adamson, San Diego, CA, United States of America
97 - Early Bleeding is Associated with Increased Length of Stay and Early Death in LVAD Recipients
Presentation Number
97
Session Name
SESSION 29 - ORAL: Anticoagulation and Bleeding Complications in MCS Patients
Date
Thu, Apr 23, 2020
Time
02:00 PM - 03:45 PM
Authors
- V. Jeevanandam, Chicago, IL, United States of America
- A. Tatooles, Oak Lawn, IL, United States of America
- C. Milano, Durham, NC, United States of America
- A. Itoh, St. Louis, MO, United States of America
- C. Selzman, Salt Lake City, UT, United States of America
- M. Jacoski, Minneapolis, MN, United States of America
- F. Pagani, Ann Arbor, MI, United States of America
- M. Slaughter, Louisville, KY, United States of America